BCS vs V
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Barclays PLC (BCS) exhibits weak financial health with a Piotroski F-Score of just 2/9, indicating significant fundamental deterioration. Despite strong recent price performance and a low forward P/E of 8.96, the stock trades above both the Graham Number ($17.26) and intrinsic value estimate ($15.26), suggesting overvaluation. Profitability margins are strong, but ROA is extremely low at 0.44%, and earnings growth is negative both year-over-year and quarter-over-quarter. Combined with bearish insider activity and weak technical trend scores, the risk-reward profile is unattractive.
V shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Key strengths include strong valuation and growth metrics.
Compare Another Pair
Related Comparisons
BCS vs V: Head-to-Head Comparison
This page compares Barclays PLC (BCS) and Visa Inc. (V) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.